Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-21 Sale | 2026-09-23 10:06 am | Pharvaris N.V. | PHVS | Nassif David W. CFO / CLO | 6,000 | $36.47 | $218,801 | 113,800 (Direct) | View |
| 2026-05-21 Sale | 2026-05-26 5:42 pm | Pharvaris N.V. | PHVS | Nassif David W. CFO / CLO | 10,000 | $30.31 | $303,076 | 120,300 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-21 Gift | 2026-09-23 10:06 am | N/A N/A | Pharvaris N.V. | PHVS | Nassif David W. CFO / CLO | 500 | $0 | 113,800 (Direct) | View |
Ownership | 2026-03-18 2:23 pm | N/A N/A | Pharvaris N.V. | PHVS | Nassif David W. CFO / CLO | 0 | $0 | 548,925 (Direct) | View |
| 2022-02-08 Option Award | 2022-02-10 5:05 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Interim CEO, CFO | 546,500 | $0 | 546,500 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-09 6:31 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer | 17,534 | $0 | 80,310 (Direct) | View |
| 2021-12-08 Tax Withholding | 2021-12-09 6:31 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer | 6,294 | $1.42 | 80,310 (Direct) | View |